Tag: Rainer M. Blair
Danaher wraps up $5.7bn acquisition of Abcam to bolster life sciences segment
Danaher Corporation (NYSE: DHR), a renowned global science and technology innovator, has announced the completion of its acquisition of Abcam plc (NASDAQ: ABCM), a key ... Read More
Danaher to acquire protein consumables supplier Abcam for $5.7bn
Danaher Corporation (NYSE: DHR), a global science and technology innovator, has announced a definitive agreement to acquire Abcam plc (NASDAQ: ABCM), a leading global supplier ... Read More
Danaher to acquire US CDMO Aldevron for $9.6bn
Danaher Corporation has agreed to acquire Aldevron, a North Dakota-based manufacturer of plasmid DNA, mRNA, and recombinant proteins, for nearly $9.6 billion from EQT Group’s ... Read More